ZhuZhou QianJin Pharmaceutical Co.,Ltd

XSSC:600479 Stock Report

Market Cap: CN¥4.2b

ZhuZhou QianJin PharmaceuticalLtd Balance Sheet Health

Financial Health criteria checks 5/6

ZhuZhou QianJin PharmaceuticalLtd has a total shareholder equity of CN¥3.0B and total debt of CN¥56.0M, which brings its debt-to-equity ratio to 1.9%. Its total assets and total liabilities are CN¥4.5B and CN¥1.5B respectively. ZhuZhou QianJin PharmaceuticalLtd's EBIT is CN¥384.9M making its interest coverage ratio -7.5. It has cash and short-term investments of CN¥1.7B.

Key information

1.9%

Debt to equity ratio

CN¥55.97m

Debt

Interest coverage ratio-7.5x
CashCN¥1.71b
EquityCN¥3.00b
Total liabilitiesCN¥1.50b
Total assetsCN¥4.49b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 600479's short term assets (CN¥3.3B) exceed its short term liabilities (CN¥1.4B).

Long Term Liabilities: 600479's short term assets (CN¥3.3B) exceed its long term liabilities (CN¥103.5M).


Debt to Equity History and Analysis

Debt Level: 600479 has more cash than its total debt.

Reducing Debt: 600479's debt to equity ratio has increased from 0.9% to 1.9% over the past 5 years.

Debt Coverage: 600479's debt is well covered by operating cash flow (825%).

Interest Coverage: 600479 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies